MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
54.32
+2.46 (4.74%)
Nov 22, 2024, 4:00 PM EST - Market closed
MLTX Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -80.77 | -36.01 | -49.97 | -64.37 |
| Depreciation & Amortization | 0.09 | 0.01 | 0.01 | 0.01 |
| Asset Writedown & Restructuring Costs | - | - | - | 5.82 |
| Stock-Based Compensation | 6.95 | 7.11 | 9.65 | 10.86 |
| Other Operating Activities | -0.43 | -7.67 | -14.01 | 0.09 |
| Change in Accounts Receivable | -1.69 | -0.84 | -0.07 | -0.18 |
| Change in Accounts Payable | 7.31 | 1.58 | -1.31 | 1.88 |
| Change in Other Net Operating Assets | -11.92 | -6.96 | -0.2 | 3.68 |
| Operating Cash Flow | -80.46 | -42.78 | -55.89 | -42.21 |
| Capital Expenditures | -0.63 | -0.28 | -0.02 | -0.06 |
| Investment in Securities | 59.23 | -24.9 | -32.32 | - |
| Investing Cash Flow | 58.6 | -25.18 | -32.34 | -0.06 |
| Total Debt Issued | - | - | - | 18 |
| Short-Term Debt Repaid | - | - | -15 | - |
| Total Debt Repaid | - | - | -15 | - |
| Net Debt Issued (Repaid) | - | - | -15 | 18 |
| Issuance of Common Stock | 83.8 | 482.45 | 0.05 | 0.13 |
| Repurchase of Common Stock | -0 | - | - | -0.01 |
| Other Financing Activities | -4.22 | -2.75 | 134.65 | - |
| Financing Cash Flow | 79.58 | 479.7 | 119.69 | 51.92 |
| Foreign Exchange Rate Adjustments | -0.23 | -0.08 | 0.01 | 0 |
| Net Cash Flow | 57.49 | 411.66 | 31.47 | 9.65 |
| Free Cash Flow | -81.09 | -43.06 | -55.91 | -42.27 |
| Free Cash Flow Per Share | -1.31 | -0.88 | -1.90 | -5.39 |
| Cash Income Tax Paid | 0.04 | 0.04 | 0 | - |
| Levered Free Cash Flow | -67.3 | -24.5 | -32.39 | - |
| Unlevered Free Cash Flow | -67.3 | -24.5 | -32.39 | - |
| Change in Net Working Capital | 5.88 | -2.49 | 1.37 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.